Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter study

被引:204
作者
Pawlik, TM
Poon, RT
Abdalla, EK
Ikai, I
Nagorney, DM
Belghiti, M
Kianmanesh, R
Ng, IOL
Curley, SA
Yamaoka, Y
Lauwers, GY
Vauthey, JN
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Unit 444,Int Cooperat Study Grp Hepatocellular Ca, Houston, TX 77030 USA
[2] Univ Hong Kong, Med Ctr, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Med Ctr, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[4] Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[5] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan
[6] Mayo Clin & Mayo Fdn, Dept Gastroenterol & Gen Surg, Rochester, MN 55905 USA
[7] Hop Beaujon, Dept Surg, Paris, France
[8] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
关键词
D O I
10.1016/j.surg.2004.12.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The role of hepatic resection in patients with hepatocellular carcinoma (HCC) and invasion of a main portal or hepatic vein branch is controversial. We evaluated the efficacy of hepatic resection and the factors affecting survival after resection in such patients. Methods. The records of 102 patients who underwent resection for HCC with major vascular invasion between 1984 and 1999 were reviewed. Prognostic factors were evaluated by univariate and multivariate analysis. Results. The study included 87 men and 15 women. The median age was 59 years. The perioperative mortality rate, was 5.9%. Median survival was 11 months (median follow-up, 93 months). The 1-, 3-, and 5-year survival rates were 45%, 17%, and 10%; the longest-living survivor was still alive at 14.8 years. Absence of moderate to severe fibrosis and absence of high nuclear grade were associated with a better 5-year survival rate (23% vs 5%; P = .001. and 21% vs 9%; P = .04, respectively). On multivariate analysis, moderate to severe fibrosis remained a significant predictor of both short-term (<= 6 months) and long-term (> 6 months) survival (P < .03 and P < .01, respectively). Conclusions. Hepati c resection for HCC with major vascular invasion is associated with median survival exceeding historical survival in patients not treated surgically. Patients with HCC and major vascular invasion who derive long-term benefit from resection,have no or minimal underlying fibrosis.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 52 条
[1]   SAMPLING VARIABILITY ON PERCUTANEOUS LIVER-BIOPSY [J].
ABDI, W ;
MILLAN, JC ;
MEZEY, E .
ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (06) :667-669
[2]  
AKASHI Y, 1991, HEPATOLOGY, V14, P262, DOI 10.1002/hep.1840140210
[3]  
[Anonymous], 1990, ANN SURG, V211, P277
[4]  
[Anonymous], 2000, HPB, DOI DOI 10.1080/136518202760378489
[5]   Sampling variability of liver fibrosis in chronic hepatitis C [J].
Bedossa, P ;
Dargère, D ;
Paradis, V .
HEPATOLOGY, 2003, 38 (06) :1449-1457
[6]   Underlying liver disease, not tumor factors, predicts long-term survival alter resection of hepatocellular carcinoma [J].
Bilimoria, MM ;
Lauwers, GY ;
Doherty, DA ;
Nagorncy, DM ;
Belghiti, J ;
Do, KA ;
Regimbeau, JM ;
Ellis, LM ;
Curley, SA ;
Ikai, I ;
Yamaoka, Y ;
Vauthey, JN .
ARCHIVES OF SURGERY, 2001, 136 (05) :528-534
[7]   Prognostic prediction and treatment strategy in hepatocellular carcinoma [J].
Bruix, J ;
Llovet, JM .
HEPATOLOGY, 2002, 35 (03) :519-524
[8]   PROGNOSTIC FACTORS OF HEPATOCELLULAR-CARCINOMA IN THE WEST - A MULTIVARIATE-ANALYSIS IN 206 PATIENTS [J].
CALVET, X ;
BRUIX, J ;
GINES, P ;
BRU, C ;
SOLE, M ;
VILANA, R ;
RODES, J .
HEPATOLOGY, 1990, 12 (04) :753-760
[9]   Protection of the liver during hepatic surgery [J].
Clavien, PA ;
Emond, J ;
Vauthey, JN ;
Belghiti, J ;
Chari, RS ;
Strasberg, SM .
JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (03) :313-327
[10]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO